SCHEMBL13320185

SCHEMBL13320185

CCCCC(CC)Cn1c2ccc(OC)cc2c2cc(C(=O)CC(C)=O)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 1/20 0.43
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
TP53 P04637 1/20 0.41
PLA2G2A P14555 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
PTGER4 P35408 1/20 0.38
PGR P06401 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
RORA P35398 1/20 0.38
RORC P51449 1/20 0.38
RORB Q92753 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1980186 0.82 CNR2 (0.47) KDM4EHSD17B10CNR1CNR2TP53
SCHEMBL25515583 0.80 CNR2 (0.56) KDM4ECNR1CNR2ALDH1A1MAPT
SCHEMBL14667868 0.78 PTGER4 (0.65) KDM4EHSD17B10PLA2G2ATDP1ALDH1A1
SCHEMBL13640265 0.78 CNR2 (0.44) KDM4EHSD17B10CNR1CNR2ALDH1A1
SCHEMBL27961708 0.77 TSHR (0.43) KDM4ECNR2TP53ALDH1A1TSHR
SCHEMBL23801802 0.77 ALDH1A1 (0.45) KDM4EHSD17B10CNR1CNR2TP53
SCHEMBL12597391 0.75 ALDH1A1 (0.42) KDM4EHSD17B10CNR2TP53ALDH1A1
SCHEMBL1978626 0.74 CNR2 (0.62) KDM4ECNR1CNR2ALDH1A1MAPK1
SCHEMBL25515668 0.74 CNR2 (0.40) CNR1CNR2PLA2G2AMEN1KMT2A
SCHEMBL23802471 0.74 CNR2 (0.40) KDM4EHSD17B10CNR1CNR2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338081-B2 Alkali-developable photosensitive resin composition and β-diketone compound ADEKA CORPORATION (JP) 2012-12-25 US disclosed
US-8338081-B2 Alkali-developable photosensitive resin composition and β-diketone compound ADEKA CORPORATION (JP) 2012-12-25 US disclosed
US-20100129753-A1 ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION AND BETA-DIKETONE COMPOUND ADEKA CORPORATION (JP) 2010-05-27 US disclosed
US-20100129753-A1 ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION AND BETA-DIKETONE COMPOUND ADEKA CORPORATION (JP) 2010-05-27 US disclosed
EP-2175320-A1 ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION AND -DIKETONE COMPOUND Adeka Corporation (JP) 2010-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100129753-A1 ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION AND BETA-DIKETONE COMPOUND RPS14, ACAD11, OR10J3 KDM4E 1572/4885HSD17B10 278/4885CNR1 1737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.